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Hepatocellular carcinoma (HCC) is a major leading cause of cancer death in Taiwan. The prognosis will be
fatal without treatment. However, about 80 cases of the rare phenomenon of spontaneous remission of
HCC have been reported in the English literature.
A 61 year old asymptomatic woman visited our outpatient clinic (OPC) with a high alpha-fetal protein
(AFP) level. A computed tomogram (CT) revealed a 4.1 cm hypervascular tumor (arterial phase) at S4 of
the liver and washed out in venous phase. Her Hepatitis B Surface Antigen (HBsAg) was negative and
Hepatitis C Antibody (anti-HCV) was positive. This patient also had esophageal varices. She refused any
treatment and returned to our OPC about 2 years later. Her AFP level was 11.8 ng/ml. The following CT
scan revealed a small amount of cirrhosis, but no mass, in the liver, so that spontaneous remission of HCC
was determined. She was treated by oral diuretics. Here we report the case and review of literature.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatocellular carcinoma (HCC) is the third most common
cancer and is a leading cause of cancer death in Taiwan.1 The
prognosis is fatal without any treatment, and the 1- 2- and 3-year
survival rate is 54%, 40%, and 28%, respectively.2,3 Even with treat-
ment, the mortality of this disease is still very high, and the median
survival is 17.7 months, while the 5-year survival rate is 10.7%.4
Spontaneous remission of malignant tumors is a rare phenome-
non, and the ﬁrst case deﬁned in 1959 by Cole and Everson.5
Spontaneous remission of HCC is an extremely rare phenomenon
and the underlying mechanisms of HCC with spontaneous regres-
sion still remain unclear. Two mechanisms have been suggested to
explain the etiology of HCC with spontaneous regression, either
through tumor ischemia, or systemic inﬂammation.6 However,
those mechanisms cannot appropriately explain all reported cases
of HCC with spontaneous regression. We report a case of HCC
without any treatment, and spontaneous partial regression was
noted.ery, Department of Surgery,
Boulevard Sect. 4, Taichung
.
ncology Society.
Society. Production and hosting by2. Case report
A 61 years old Taiwanese woman with Child-Pugh B liver
cirrhosis due to HCV infection visited our outpatient clinic (OPC) on
15th/May/2012 for elevated liver enzymes noted by a local medical
clinic. Bodyweight loss of 5 kgwithin onemonthwas also reported.
She had no history of hypertension, diabetes mellitus or other
systemic diseases. She denied alcohol drinking and cigarettes
smoking. She took no drugs. Results of a physical examinationwere
unremarkable, and there was no abdominal pain, jaundice, nor
general edema. The abdomen was soft and ﬂat, with neither
palpable masses nor ascites.
At that time, her laboratory examinations showed hemoglobin
(Hb) of 10.4 g/dl (normal: 11.3e15.3), and platelets of 36,000/mm3
(normal: 150,000e400,000), and WBC count of 3800/mm3
(normal: 4000e11,000). The liver function showed serum albumin
was 3.2 g/dl, total bilirubinwas 1.7 mg/dl, alkaline phosphotate was
184 U/l (normal190), aspartate aminotransferase (AST) was 70 U/l
(normal: 8e38), alanine aminotransferase (ALT) was 56 U/l
(normal: 10e35), alpha-fetal protein (AFP) was 624 ng/ml (normal
<12), international normalized ratio (INR) was 1.52 (normal:
0.85e1.15). Her HBsAg was negative and anti-HCVwas positive. Her
Child-Pugh score was 7 (Child-Pugh class B).7 Abdominal ultraso-
nography showed one bulging tumor, 4.2 3.2 cm in size. The triple
phase CT scan of the liver demonstrated an ill-deﬁned low densityElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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naud's segement 4b, S4b),8 approximately 41 mm in diameter, with
early enhancing in the arterial phase and washout in the delayed
phase on the after contrast medium CT, that showed compatibility
with HCC (Fig. 1). Para-esophageal varices, multiple collateral ves-
sels in the abdomen, mild ascites and splenomegaly were also
noted. The diagnosis of HCC was determined based on a single
positive imaging technique showing hypervascularization associ-
ated with more than 400 ng/ml of AFP level. In addition, the patient
did not take any medications and surgical treatment in our clinic,
and also did not return to our OPC to follow up her HCC
progression.
Over 2 years later, she returned to our OPC on 27th/July/2014
after developing abdominal distension and leg edema over the
previous three weeks. The physical examination showed abdomen
distension with ascites and pitting edema. Her AFP level was
11.8 ng/ml, serum albumin was 2.4 g/dl, total bilirubin was 1.7 mg/
dl, AST was 61 U/l, ALT of was 38 U/l, alkaline phosphotate was
132 U/l. The following triple phase CT scan of the liver revealed no
obvious mass in the liver, with a poor enhancing lesion over the
previous HCC site (Fig. 2). Her liver cirrhosis status with progression
was noted with clinic symptoms attacked. She denied any treat-
ment (including invasive procedures, radiation, medications, and
herb drugs) and was only treated with oral diuretics for controlling
symptoms during these two years. She also reported no gastro-
intestine bleeding, shock, trauma, blood transfusion, or other spe-
cial episodes. In addition, she did not attend regular follow-up
appointments due to personal reasons. Approximately thirty
months after initial diagnosis, the last triple phase CT scan of the
liver still revealed no obvious tumor recurrence (Fig. 3). Taken
together, a patient with spontaneous remission of HCC was deter-
mined in this case.
3. Discussion
Here we report a rare case of HCC with spontaneous regression,
where the evidence of tumor remission was conﬁrmed by a series
of CT scans and associated with the decrease of serum AFP levels
without any treatment.
Spontaneous remission of cancer is a rare phenomenon, and
deﬁned by Cole and Everson as partial or complete disappearance
of a malignant tumor in the absence of any treatment, or in the
presence of the therapy which is considered to be inadequate to
exert a signiﬁcant inﬂuence on neoplastic disease.5 Most malignant
tumor with spontaneous regression occurs on renal cell carcinoma,
neuroblastoma, melanoma, and choriocarcinoma; these consti-
tuted more than half of all cases.9 Incidence rate of spontaneous
regression of cancer is estimated to be 1 in 60,000e100,000 cancer
patients.10 Unfortunately, spontaneous regression of HCC is a more
rare event, and the reported incidence rate is 1 in 140,000 cases ofFig. 1. A 41-mm mass in the S4 of the liver with early enhancing in the arterial phase (a) aHCC.11 The ﬁrst case of HCC with spontaneous regression is
described by Johnson and colleagues in 1972.12 Until now, about 80
cases have been reported in English literature. The ﬁrst biopsy-
proven Taiwanese patient had been documented in 1992.13 After
review the literatures and several clinical events were documented,
including abstinence from alcohol, androgen withdrawal, persis-
tent fever, pain, gastrointestinal bleed requiring transfusion, herbal
therapies, use of vitamin K, anti-estrogen therapy, sepsis, blood
transfusion, portal vein tumor thrombosis, angiography related
angiospasm or arterial thrombosis.6,9,14e20 However, the most
appropriate etiology to explain possible mechanisms for the above
clinical events are still unclear.
Besides, the possibility of a tumor with spontaneous regression
seem not to be associated with tumor size, tumor number, the level
of serum alpha-fetal protein presence or not of distance metastasis
distance metastasis.21 Two common mechanisms of HCC with
spontaneous regression were suggested: tumor hypoxia and sys-
temic inﬂammatory activation. Tumor hypoxia mechanism con-
tributes about 28.0% of all recorded case in English literatures.6 The
clinical events include portal vein tumor thrombosis, angiography
related angiospasm or arterial thrombosis, rapid growth of the
tumor, massive gastrointestinal bleed, and so on. This hypothesis
can easily be accepted just like using transhepatic arterial chemo-
embolization (TACE) or the anti-angiogenesis effect of sorafenib to
treat HCC.22e24
Another possible mechanism is systemic inﬂammatory activa-
tion, which contributes more (about 33.3%) than tumor hypoxia in
all recorded cases in English literature.6 We trust that some clinical
events activate an inﬂammatory mechanism that leads to tumor
regression, due to elevation of several cytokine and biomarkers (ex:
IL-2, IL-6, IL-12, IL-18, interferon (IFN) e gamma, tumor necrosis
factor (TNF) e alpha) were documented.25e31 Besides, tumor hyp-
oxia mechanism cannot fully explain spontaneous regression of
HCC with distance metastasis.32 Some pathological evidences of an
active inﬂammation mechanism were described as the presence of
overactivated macrophages (CD163þ) or lymphocytic inﬁltra-
tion.33,34 The most appropriate etiology of spontaneous tumor
regression still remains uncertain, but activated inﬂammation
mechanism must play an important role.
We described herein a case of HCC with spontaneous regression
without any obvious clinical markers of tumor hypoxia or systemic
inﬂammatory activation. Unfortunately, this case was not proven
histologically due to the patient refusing any invasive treatment.
The diagnosis of HCC was determined based on a single positive
imaging technique showing hypervascularization and associated
with more than 400 ng/ml of AFP level, according to the Barcelona
Clinic Liver Cancer (BCLC) staging classiﬁcation.35
This case demonstrates to us there are still some unknown
mechanisms affecting tumor regression. Severe cirrhosis related
tumor hypoxia might be a possible mechanism causing thisnd washout in the delayed phase (b) on triple phase CT scan of the liver (May/2012).
Fig. 2. The previous HCC site showed spontaneous regression without treatment. Some Ascites was also noted. (a) arterial phase (b) delayed phase on triple phase CT scan of the
liver (July/2014).
Fig. 3. The following triple phase CT scan of the liver still revealed no obvious tumor recurrence. Still some ascites was also noted. (a) arterial phase (b) delayed phase (Nov./2015).
S.-C. Luo et al. / Journal of Cancer Research and Practice 3 (2016) 128e131130particular case of tumor regression, but it can not be proven. The
severity of cirrhosis seemed unrelated to the possibility of tumor
with spontaneous regression after reviewing literature.21 The
interesting phenomenon of tumor regression is undoubtedly a hint
to help us to ﬁnd the new treatment therapies for HCC. The
collection and accumulation of those special cases is the ﬁrst step
towards advancing understanding of the phenomenon.Conﬂict of interest
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